Polar Capital’s Intersect ENT, Inc XENT Stock Holding History

Polar Capital’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-13,485	Closed	-$183K	–	328
2020 Q2	$183K	Sell	13,485 -947,842	-99%	-$11M	﹤0.01%	277
2020 Q1	$11.4M	Buy	961,327 +595,988	+163%	+$13.2M	0.12%	158
2019 Q4	$9.1M	Buy	+365,339	New	+$7.4M	0.08%	206
2015 Q4	–	Sell	-444,652	Closed	-$10.4M	–	297
2015 Q3	$10.4M	Buy	444,652 +100,074	+29%	+$2.76M	0.21%	139
2015 Q2	$9.87M	Buy	+344,578	New	+$9.03M	0.19%	149

Other funds holding XENT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Polar Capital's XENT Position: Q3 2020 in Review

Polar Capital sold out of Intersect ENT, Inc (XENT) in Q3 2020, closing a stake of 13,485 shares — an estimated $183K sold.

Polar Capital first reported a position in XENT in Q2 2015 and held it in 5 quarters. The position peaked at $11.4M in Q1 2020. 112 funds tracked by Wall St. Rank hold XENT as of Q3 2020.

Polar Capital reported no remaining Intersect ENT, Inc position as of Q3 2020 after selling out during the quarter.
Polar Capital sold 13,485 Intersect ENT, Inc shares in Q3 2020, an estimated $183K.
Polar Capital first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 5 quarters.
Polar Capital's Intersect ENT, Inc position peaked at $11.4M in Q1 2020.
112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.